about
Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the diseaseMissense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesisOxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q₁₀ effect on clinical improvementOxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.Coenzyme q10 therapyClinical symptoms in fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma.Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia?Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.Diets based on virgin olive oil or fish oil but not on sunflower oil prevent age-related alveolar bone resorption by mitochondrial-related mechanisms.Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease.Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the diseaseAMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia?Utility of Periodontal exploration in patients with Fibromyalgia.NLRP3 inflammasome is activated in fibromyalgia: the effect of coenzyme Q10.Oxidative stress and mitochondrial dysfunction in fibromyalgia.Effect of coenzyme Q10 evaluated by 1990 and 2010 ACR Diagnostic Criteria for Fibromyalgia and SCL-90-R: four case reports and literature review.Clinical applications of coenzyme Q10.Stabilization of apoptotic cells: generation of zombie cells.Apoptotic cells subjected to cold/warming exposure disorganize apoptotic microtubule network and undergo secondary necrosis.Apoptotic microtubules delimit an active caspase free area in the cellular cortex during the execution phase of apoptosis.Recovery of MERRF fibroblasts and cybrids pathophysiology by coenzyme Q10.[Low levels of serotonin in serum correlates with severity of fibromyalgia].Clinical symptoms in fibromyalgia are associated to overweight and lipid profile.Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia.Cytotoxic effects of amitriptyline in human fibroblasts.Body fat and metabolic age as indicators of inflammation and cardiovascular risk.Coenzyme q10 regulates serotonin levels and depressive symptoms in fibromyalgia patients: results of a small clinical trial.NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.NLRP3 inflammasome: a new target in major depressive disorder.Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients.Mutation in cytochrome b gene of mitochondrial DNA in a family with fibromyalgia is associated with NLRP3-inflammasome activation.Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome.Critical role of AMP-activated protein kinase in the balance between mitophagy and mitochondrial biogenesis in MELAS disease.Metformin and caloric restriction induce an AMPK-dependent restoration of mitochondrial dysfunction in fibroblasts from Fibromyalgia patients.Aging-related changes in inflammatory and LKB1/AMPK gene expression in fibromyalgia patients.Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient.Mitochondrial dysfunction in skin biopsies and blood mononuclear cells from two cases of fibromyalgia patients.[Mitochondrial dysfunction in fibromyalgia and its implication in the pathogenesis of disease].
P50
Q21195362-8EFAEBE6-7A83-4A24-A766-9872BE73D69EQ28115898-14780E95-2415-498C-BB06-04A92A234783Q28482427-CEBA69E3-D7C8-4D84-928B-CF3131A70C70Q33625254-8F66E80A-DB47-44AF-A87E-64FBBCC70092Q33956936-D466C546-8ADC-44F1-8035-81C12D349FCDQ34064822-F6008157-6AEC-4401-A4B0-B52E4BEC0C62Q34330854-1340EC60-71BD-47EB-B9C3-6D3C01F203F0Q34685307-9CC3570F-92C2-4D77-AFAE-ADAAD674FA33Q34997287-BD1E758F-4C4D-4282-AE5F-8CB50F44E1FDQ35137321-DD51DCB5-894E-4805-BA19-6AC0730CC0D6Q35686212-A40B723C-2001-4B62-AD6A-990633A861F2Q36419316-06E55BA4-291E-475E-9818-C74BC0C947A5Q36549279-5B169320-583C-43D3-9819-5828A6EA3CA6Q36562600-B190AD5F-58EB-43AD-9983-FA2FEEED692BQ37537756-385DA466-FDB1-48E0-A8C9-E0A8D6886DA8Q37602813-414EFF4F-A1C3-4C4B-AAD8-78DF8C0F434CQ37737963-4518A7E3-1E55-48FA-A224-27324501E800Q38150556-21E4AD83-4BE2-48E6-AD4E-E557BEAD68FEQ38175736-2089DF96-A1CB-46B3-841C-3E1B344A8467Q38966530-6590A956-41A4-4DEB-B023-C06005440B68Q38975044-5EDA50CB-D4FE-47DD-A276-9505E099112EQ39183617-BC5AD514-98A2-4629-96CA-24B98B6068D8Q39392555-15419DC3-11B1-4DA6-9136-BA1BAE769E7DQ42998464-C1769F89-2693-4B3D-AF69-0DF4DFD62124Q44961170-01CC223D-9846-485E-8FDB-A47277CCB898Q46169702-550FED95-D6E2-45C3-AD03-F85EE8FD904DQ46916394-EEB3A441-92AA-4D3E-9B05-F83DBBB48E15Q48255498-2ACCD553-EE7D-439D-8A07-A4A33345B329Q48352088-C8708FF7-DB8F-42C5-AA31-CE13A9762B8BQ48354329-A6FA674D-79E6-4FCC-8E53-14CC52D0B3CFQ48361495-D1B1EC8F-8131-4566-B748-F335E2A4800AQ48799106-5A1AA520-0793-4ECD-B76D-07E2405F0119Q50278049-19C67000-CB3C-49B3-915C-3E2E87AF001DQ50437247-A0765A39-998D-4A60-9A98-3B150EDB6819Q50437571-24EF1EB5-F1F7-4D8E-BB84-4AF9AD8DCD7BQ50449918-74C9675C-FF0B-4B14-A4FC-247E22E206DFQ50476380-A53B4EE6-6F63-4546-B391-5EE32486BA7BQ50505146-1EF2E6F7-56A6-448E-BDB3-8B0A61D113CCQ50571739-48F88120-B151-4391-B94D-A423CC7ADBB5Q50579641-3780AF5C-F34A-4FBE-8616-E463301BC99F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mario D Cordero
@ast
Mario D Cordero
@en
Mario D Cordero
@es
Mario D Cordero
@nl
Mario D Cordero
@sl
type
label
Mario D Cordero
@ast
Mario D Cordero
@en
Mario D Cordero
@es
Mario D Cordero
@nl
Mario D Cordero
@sl
prefLabel
Mario D Cordero
@ast
Mario D Cordero
@en
Mario D Cordero
@es
Mario D Cordero
@nl
Mario D Cordero
@sl
P1053
L-8006-2014
P-9426-2017
P106
P21
P31
P3829
P496
0000-0003-0151-3644
P569
2000-01-01T00:00:00Z